The Johns Hopkins Research Institute says that malaria affects 300 to 500 million people yearly and that five percent of African children are killed by Malaria, almost 3000 each day.While the United Nations Children Fund (UNICEF) says that malaria kills one child every 30 seconds and about 3000 each day
July 29, 2014 – African countries worst hit by malaria fever may have the first vaccine by 2015 if GlaxoSmithKline (GSK) receives approval to distribute the vaccine by the year 2015.
Malaria kills about 800,000 people each year, most of which are from Africa and other third world countries. But the Johns Hopkins Research Institute says that malaria affects 300 to 500 million people yearly and that five percent of African children are killed by Malaria, almost 3000 each day.
While the United Nations Children Fund (UNICEF) says that malaria kills one child every 30 seconds and about 3000 each day.
However during the trial, researchers found that for every 1,000 children who received the vaccine, an average of 800 cases of illness could be prevented. “And in continuing trials it went on to provide protection some 18 months after the injections were given”, the BBC reported.
“In the most advanced trial to date, involving several African countries, 1,500 infants and children were given the RTS vaccine. Revisiting them 18 months after the last injection, researchers found that in young children the vaccine almost halved the number of cases of malaria. And for infants (who were aged six to 12 weeks at first vaccination) the drug reduced episodes of malaria by a quarter. Though the effectiveness of the vaccine was seen to wane over time, the report suggests it may have the largest impact in areas with high rates of disease”, experts have said.
